|
URSO Forte® Scored and URSO 250® (ursodiol tablets, USP) are bile acids available as 500 mg and 250 mg film-coated tablets for oral administration. URSO Forte® Scored and URSO 250® are the only ursodiols approved by the Food and Drug Administration for the treatment of patients with Primary Biliary Cirrhosis (PBC), a chronic liver disease that slowly destroys the ducts that drain bile in the liver. The recommended adult dosage for URSO Forte® Scored and URSO 250® in the treatment of PBC is 13-15 mg/kg/day administered in two to four divided doses with food.
URSO Forte® Scored and URSO 250® have more than 10 years of clinical studies that prove its effectiveness and safety to delay the progression of PBC, normalize liver function tests, decrease the incidence of esophageal varicies by 60%, and significantly improve transplant-free survival to the point that non-cirrhotic PBC patients will have a survival rate similar to that of the general population.
|
